Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2025	Dec. 31, 2024
Cash and cash equivalents
Restricted cash	$ 1,330	$ 427
Accumulated depreciation and amortization	11,754	10,739
Other assets, reserves for credit losses	20	27
Liabilities
Long-term debt	$ 57,787	$ 49,715
Shareholders’ Equity
Preferred shares, par value (in dollars per share)	$ 1.667	$ 1.667
Preferred shares authorized (in shares)	20,000,000	20,000,000
Preferred shares, issued (in shares)	1,600	1,600
Preferred shares, outstanding (in shares)	1,600	1,600
Common shares, par value (in dollars per share)	$ 0.20	$ 0.20
Common shares, authorized (in shares)	3,600,000,000	3,600,000,000
Common shares, issued (in shares)	689,000,000	702,000,000
Common shares, outstanding (in shares)	689,000,000	702,000,000
Accumulated other comprehensive income (loss)	$ (3,249)	$ (3,395)
Card Member Receivables
Cash and cash equivalents
Financing receivables, gross	61,023	59,411
Allowance for credit losses	200	171
Card Member Loans
Cash and cash equivalents
Financing receivables, gross	144,814	139,674
Allowance for credit losses	5,868	5,679
Other Loans
Cash and cash equivalents
Financing receivables, gross	10,518	9,232
Allowance for credit losses	287	194
Variable Interest Entity, Primary Beneficiary
Cash and cash equivalents
Restricted cash	5	6
Restricted investments	1,233	82
Liabilities
Long-term debt	14,019	13,880
Variable Interest Entity, Primary Beneficiary | Card Member Receivables
Cash and cash equivalents
Financing receivables, gross	6,710	3,927
Variable Interest Entity, Primary Beneficiary | Card Member Loans
Cash and cash equivalents
Financing receivables, gross	$ 26,354	$ 28,278